Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: The Rotterdam study

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 1, 2013, Pages 58-64

  Lahousse, Lies ^a,b   Van Den Bouwhuijsen, Quirijn J A ^b   Loth, Daan W ^b,c   Joos, Guy F ^a   Hofman, Albert ^b,d   Witteman, Jacqueline C M ^b   Van Der Lugt, Aad ^b   Brusselle, Guy G ^a,b   Stricker, Bruno H ^b,c,d  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Inspectorate of Health Care   (Netherlands)

^d Netherlands Center for Healthy Ageing   (Netherlands)

Author keywords

Atherosclerotic; Carotid intima media thickness; Chronic airflow obstruction; Intraplaque hemorrhage; Plaque

Indexed keywords

AGED; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIROMETRY;

AGED; AGED, 80 AND OVER; BRONCHITIS; CAROTID STENOSIS; CROSS-SECTIONAL STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING; NETHERLANDS; PLAQUE, ATHEROSCLEROTIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 84871998820     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201206-1046OC     Document Type: Article

References (31)

1. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-161.
2. Rosenberg SR, Kalhan R. Dying from, and with, chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183:960-962.
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
4. Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City heart study. Int J Epidemiol 2001;30:145-151. (Pubitemid 32203804)
5. Doehner W, Haeusler KG, Endres M, Anker SD, MacNee W, Lainscak M. Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. Respir Med 2011;105:S12-S19.
6. Hennerici MG. The unstable plaque. Cerebrovasc Dis 2004;17:17-22. (Pubitemid 38134843)
7. van den Bouwhuijsen QJ, Vernooij MW, Hofman A, Krestin GP, van der Lugt A, Witteman JC. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J 2011;33:221-229.
8. Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006;37:818-823. (Pubitemid 43731915)
9. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello C, Small R, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005;111:2768-2775. (Pubitemid 40791548)
10. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-1672. (Pubitemid 37243650)
11. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, Kuipers EJ, Nijsten TE, Stricker BH, Tiemeier H, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26:657-686.
12. Iglesias del Sol A, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: relation to incident myocardial infarction. The Rotterdam Study. Eur Heart J 2002;23:934-940.
13. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillard T, Fahy B, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946. (Pubitemid 38807371)
14. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, MacNee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
15. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and p4 medicine. Am J Respir Crit Care Med 2011;183:1129-1137.
16. van Gestel YR, Flu WJ, van Kuijk JP, Hoeks SE, Bax JJ, Sin DD, Poldermans D. Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med 2010;104:712-716.
17. Frantz S, Nihlen U, Dencker M, Engstrom G, Lofdahl CG, Wollmer P. Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods. Clin Physiol Funct Imaging 2012;32:120-125.
18. Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, Kawut SM, Watson K. Subclinical atherosclerosis, airflow obstruction and emphysema. The Mesa lung study. Eur Respir J 2012;39:846-854.
19. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, Hattori N, Hara H, Kohno N. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009;179:35-40.
20. Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis 2005;180:367-373. (Pubitemid 41072908)
21. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. The British regional heart study. Stroke 1999;30:841-850. (Pubitemid 29156378)
22. Agusti A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;184:507-513.
23. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2012;66:585-590.
24. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. AmJ RespirCritCare Med 2012;185:1065-1072.
25. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32:962-969.
26. Engstrom G, Hedblad B, Valind S, Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from 'men born in 1914', Sweden. Atherosclerosis 2001;155:237-243. (Pubitemid 32167145)
27. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis: a 9-year population-based follow-up study in women. Circulation 1993;88:2156-2162. (Pubitemid 23326095)
28. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, Poewe W, Willeit J. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Stroke 2002;33:2170-2176. (Pubitemid 35014624)
29. McAllister DA, Maclay JD, Mills NL, Mairl G, Miller J, Anderson D, Newby DE, Murchison JT, MacNee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:1208-1214. (Pubitemid 350256474)
30. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011;378:1015-1026.
31. Ota H, Yu W, Underhill HR, Oikawa M, Dong L, Zhao X, Polissar NL, Neradilek B, Gao T, Zhang Z, et al . Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb Vasc Biol 2009;29:1696-1701.